Medicine and Dentistry
Implantable Automatic Defibrillator
100%
Ventricular Tachycardia
70%
Sudden Cardiac Death
54%
Primary Prevention
52%
Heart Failure
44%
Catheter Ablation
43%
Heart Ventricle Arrhythmia
38%
Arrhythmogenic Right Ventricular Dysplasia
35%
Cardiovascular System
35%
Hazard Ratio
35%
Shock (Circulatory)
34%
Catheter Ablation
28%
Cardiomyopathy
27%
Cardiac Resynchronization Therapy
26%
Faintness
22%
Rhythm
20%
QT Interval
17%
Patient Referral
17%
Heart Atrium Thrombosis
17%
Self Concept
17%
Heart Disease
17%
Heart Muscle Biopsy
17%
Long QT Syndrome
17%
Prevalence
17%
QT Prolongation
17%
Positron Emission Tomography
17%
Disease
15%
Retrospective Cohort Study
15%
Biopsy
13%
Heart Left Ventricle Ejection Fraction
12%
Proarrhythmia
11%
Clinical Trial
11%
Heart Rhythm
9%
Congenital Long-QT Syndrome
8%
Tertiary Care
8%
Electrocardiogram
8%
Health Care
8%
Disopyramide
8%
Ischemic Cardiomyopathy
8%
Coronary Artery Disease
8%
Diagnosis
7%
Side Effect
7%
Recurrent Disease
7%
Drug Therapy
7%
Antiarrhythmic Agent
7%
Pediatrics
6%
Secondary Prevention
5%
Ejection Fraction
5%
Lopinavir/Ritonavir
5%
Post-Hoc Analysis
5%
Keyphrases
Heart Failure
35%
Confidence Interval
25%
Heart Failure Hospitalization
22%
Implantable Defibrillator
19%
Hazard Ratio
17%
Access Roads
17%
Ischemic Scar
17%
Optimal Force
17%
Shock
17%
Return of Results
17%
Inappropriate ICD Therapy
17%
Left Atrial Thrombus
17%
Sudden Cardiac Death Prevention
17%
Long QT Syndrome
17%
Proarrhythmia
17%
Cardiogenetics
17%
QT Prolongation
17%
Electronic Gaming
17%
Genomic Research
17%
Disopyramide
17%
Lamin A/C Cardiomyopathy
17%
Cardiac Resynchronization Therapy
17%
Fludeoxyglucose
17%
Cardiomyopathy in children
17%
Implantable Cardioverter-defibrillator Shock
14%
Localization System
14%
Lesion Formation
10%
Breakthrough Cardiac Events
10%
Site Localization
10%
Left Ventricular Ejection Fraction
10%
Shock Hazard
8%
Fiscal Pressure
8%
Corrected QT Interval
8%
Lopinavir
8%
Baseline Testing
8%
Unexplained Syncope
8%
Medical Testing
8%
Prolonged QTc
8%
Cardioverter-defibrillator
7%
Trans-septal Approach
7%
Practical Tips
7%
Mechanical Circulatory Support
7%
Device Complications
5%
Mortality Risk
5%
Implantable Cardioverter-defibrillator Therapy
5%
ICD Registry
5%
Special Treatment
5%
Cardiac Morbidity
5%
Side Effect Profile
5%
Annual Symposium
5%